Announced Mon, 6 Apr · 17:36 IST

The Company wishes to inform that a Meeting of the RIghts Issue Committee will be held on 9th April 2026 to approve some key parameters of the upcoming Rights Issue

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+27.5%1-day move

₹7.92

prior close

₹8.59

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+3.3+2.3+2.2+27.5+40.8+52.7+46.0+49.9+52.9+50.5+45.1+50.4+5.6

Up moveDown movePending

AI summary

Indrayani Biotech Ltd has informed BSE that a Rights Issue Committee meeting will be held on April 9, 2026 to finalize parameters of a proposed partly paid-up Rights Issue. The committee will determine the total number of Rights Equity Shares to be issued, fix the Rights Issue Price, Rights Entitlement Ratio, Rights Issue period, and Record Date to identify eligible shareholders. The company will also formally appoint a Monitoring Agency and Banker to the Issue to manage fund flows and compliance. This is an early-stage announcement with no specific issue size or pricing details disclosed yet.

Likely market impact

This is a pre-issuance procedural announcement. The stock may experience volatility depending on market perception of dilution, but concrete impact on share price will depend on final pricing and subscription terms to be decided.